Headquartered in Leipzig, Germany, c-LEcta GmbH is a global biotechnology company specializing in enzyme engineering and bioprocess development for industrial applications, operating as part of Kerry Biotechnology.
Subscribe to see c-LEcta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
c-LEcta is a biotechnology company headquartered in Leipzig, Germany, founded in 2004. Xcout tracks 8 named people at c-LEcta, including Dr. Marc Struhalla (CEO and Founder).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for c-LEcta, with roles, board committees and tenure — see the full roster →
A few of c-LEcta's closest competitors — see the full list of competitors and alternatives →
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
Advanced Enzyme Technologies Limited is a research-driven manufacturing company that produces enzymes and probiotics for global industries. The company provides eco-safe enzyme solutions and applications for human healthcare and nutrition, animal nutrition, food and beverage processing, textiles, leather, and detergents.
Enzyan Biocatalysis GmbH is a biotechnology company headquartered in Graz, Austria, that specializes in creating innovative biosolutions to synthesize small molecules, particularly nitrogen-containing compounds.
ProtaGene is a biotechnology research company and contract research organization (CRO) partner headquartered in Heilbronn, Germany, serving the biopharmaceutical, gene, and cell therapy industries.
Immobazyme is a biotechnology company headquartered in Cape Town, South Africa, specializing in enzyme engineering, recombinant protein production, and functional protein manufacturing.
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about c-LEcta? Suggest a correction · Work at c-LEcta? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.